Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer

Author： Ouagari Khalid   Karnon Jon   Delea Thomas   Talbot Willena   Brandman Jane  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.101, Iss.1, 2007-01, pp. : 37-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden

By Lundkvist Jonas   Wilking Nils   Holmberg Stig   Jönsson Linus  

Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. : 289-299

Springer Publishing Company

Access to resources Recommend Favorite

Cost-Effectiveness of Treatment of Early Stage Endometrial Cancer

By Ashih H.   Gustilo-Ashby T.   Myers E.R.   Andrews J.   Clarke-Pearson D.L.   Berry D.   Berchuck A.  

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 208-216

Elsevier

Access to resources Recommend Favorite

Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis

By Norum J.   Olsen J. A.   Wist E. A.   Lønning P. E.  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 153-164

Informa Healthcare

Access to resources Recommend Favorite

The Extended Adjuvant Treatment Strategy in Early Breast Cancer: A New Standard of Care?

By Smith Ian E.  

American Journal of Cancer, Vol. 5, Iss. 1, 2006-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

A Cost-effectiveness Analysis of Two Rehabilitation Support Services for Women with Breast Cancer

By Gordon Louisa  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite